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aor many years, studies of atherosclerosis had
been relegated to the realm of the patholo-
gist. It has only been in the last 15 years or
so that the imaging approaches have devel-
ped the ability to perform atherosclerosis imaging
n vivo, enabling serial studies in animals and hu-
ans rather than post-mortem studies. The first ev-
dence that cardiac magnetic resonance (CMR)
ould be used to image atherosclerosis in vivo was
emonstrated in the early 1990s in a rabbit model
y a group at the University of Washington (1).
MR enabled identification of the fibrous cap and
ipid core as well as fissures within the plaque. This
ork was extended to other animal models includ-
ng mice, allowing the characterization of plaques in
he transgenic models. Subsequent studies extended
hese findings to humans, demonstrating for the
rst time the ability to image carotid atherosclerosis
n vivo using a surface coil on the neck and black
lood T1-weighted (T1-W) spin echo imaging.
alidation of CMR plaque imaging of the human
orta was later performed with transesophageal
chocardiography and validation of carotid plaque
maging by histopathology after carotid endarterec-
omy. Measurements of atherosclerotic plaque vol-
me in the aorta and carotid vessels using these
echniques have shown that statins reduce plaque
olume over a 2-year time period with minimal
hanges in lumen dimension (2). The test-retest re-
roducibility of these techniques in the carotid and
ther vascular beds such as the superficial femoral
rtery allows significant reductions in sample sizes
equired for clinical trials of pharmacologic regres-
ion of atherosclerosis.
rom the *Departments of Medicine and Radiology and the Cardiovas-
ular Imaging Center, University of Virginia, Charlottesville, Virginia;
nd the †Department of Medicine, University of California–Irvine,t
rvine, California. Dr. Kramer is supported by NIH R01 HL075792. Dr.
arula was supported by NIH R01 HL 078681 and RO1 HL 68657.The ability of CMR to differentiate plaque com-
onents in the arterial wall has advanced steadily
ver the past decade. Much of this work has been
erformed in the carotid by the group of Chun
uan, PhD, and Thomas Hatsukami, MD, whose
ork is highlighted on the cover of this issue of
JACC (3). This group has carefully validated multi-
pectral CMR of the carotid against histology in pa-
ients who were imaged prior to undergoing carotid
ndarterectomy. This multispectral imaging gener-
lly includes T1-, T2-, and proton density-weighted
maging, T1-W imaging after contrast, and a non-
ontrast angiographic technique that allow differen-
iation of the fibrous cap, lipid-rich necrotic core,
alcification, intraplaque hemorrhage, and loose ma-
rix. Prospective studies from this group have dem-
nstrated that the presence of intraplaque hemor-
hage and thin fibrous cap on CMR carotid
maging predict subsequent transient ischemic attack
r stroke. These imaging findings agree closely with
athologic studies that have highlighted similar
igh-risk features of vulnerable plaques. Other im-
ging studies using a multispectral approach in pa-
ients presenting with symptoms of acute stroke
how that American Heart Association type VI
laque, which includes intraplaque hemorrhage, is
he most powerful prognostic predictor. Additional
laque characterization approaches are under devel-
pment, including T2* imaging of changes in iron
orms within atherosclerosis (4). Lower T2* values
ere seen in carotid atherosclerosis of patients with
ymptoms as compared to those without symptoms.
The addition of various contrast agents to CMR
therosclerosis imaging has further contributed to
laque characterization. Late gadolinium enhance-
ent (LGE) helps to identify the fibrous cap in
laque within abdominal aortic aneurysms and the
mount of enhancement may be a marker of the ex-
ent of acute inflammation in the cap. Other gado-
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917inium-based agents under development such as ga-
ofluorine have been used to identify plaque in
nimal models. Gadolinium has been linked to the
argeting agents directed at inflammatory markers or
onocyte-macrophage receptors within the plaque
o improve localization and identification of vulnera-
le features of atherosclerosis. In patients prior to
arotid endarterectomy, the wash-in kinetics of gad-
linium into the carotid atherosclerosis has been
emonstrated to correlate with plaque neovascular-
zation and other features of plaque vulnerability.
nother type of contrast agent, ultra-small super-
aramagnetic iron oxides, is taken up by macro-
hages and is associated with signal loss on carotid
MR images. Signal loss is sometimes difficult to
istinguish from imaging artifacts and thus pulse se-
uences have been developed that allow positive
ontrast to be generated from these iron oxide mol-
cules. Finally, specific fibrin-targeted contrast
gents can improve localization and identification of
hrombus in the left atrium, pulmonary arteries, and
oronary arteries in animal models. Early examples
f their use in Europe have been shown in isolated
ases of aortic plaque/thrombus in humans.
Imaging plaque characteristics in the coronary ar-
ery has been the holy grail of noninvasive imaging
f atherosclerosis. T1-W black blood imaging ap-
roaches have been applied to the wall of the coro-
ary artery to demonstrate increased wall thickness
n patients with coronary artery disease but without
bstructive stenoses. Such approaches have been
sed to demonstrate increased coronary wall thick-
ess in diabetics with renal disease compared to
hose without nephropathy. Spatial resolution limi-
ations of CMR do not yet allow the differentiation
f plaque components in the coronary wall in hu-
ans. However, recent reports in our journal have
ighlighted exciting advances in this arena. One re-
ort used noncontrast T1-W imaging in patients with
table angina (5) and compared it to the computed to-
ographic angiography-verified plaque characteristics
f instability. The plaques with higher signal on
1-W imaging correlated with high risk features
dentified by intravascular ultrasound including posi-
ive remodeling, ultrasound attenuation, and spotty
alcification. This high T1 signal was previously as-
ociated with American Heart Association type VI
laques including intraplaque hemorrhage on carotid
maging. This suggests that techniques are evolving Euch that CMR would be able to identify high risk
eatures in the coronary vessels even if specific com-
onents in the coronary plaques are not fully
esolved.
LGE has also made its way to the coronary
all. Preliminary work had shown that LGE was
dentifiable in the coronary wall in patients with
stablished coronary atherosclerosis, but LGE is a
onspecific finding and can be seen in states of fi-
rosis, edema, and inflammation. A recent report
as used gadolinium and a 3-dimensional T1-W
radient echo inversion recovery pulse sequence in
group of patients after acute myocardial infarc-
ion to demonstrate that LGE of the coronary
all decreased over time after the index event (6).
lthough these authors suggested that this tech-
ique may be a marker of inflammation or edema
ithin the coronary wall, the enhancement was
ot localized to the particular site of occlusion,
nd was noted diffusely in the coronary tree.
ore work in this area is clearly needed in larger
atient cohorts with different types of coronary
yndromes to further elucidate the role of LGE of
he coronary wall in identifying high-risk features.
The application of CMR atherosclerotic plaque
maging is limited at present, it remains in the
ands of the few research laboratories that have
edicated resources and personnel to this endeavor.
greater effort is needed to train young investiga-
ors in the methodologies and background necessary
o perform studies of this kind. It will require an in-
rease in trained investigators and dissemination of
ulse sequences and specialized coils to more centers
s well as studies in larger numbers of patients for
hese research techniques to become clinical reality.
ith wider recognition of the potential contribution
f these imaging approaches, we certainly hope that
he CMR conquers this last elusive frontier of car-
iovascular imaging. iJACC remains committed to
ringing you the latest in the field.
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